Open Access

EDITORIAL

Laurence H. Klotz
Canadian Journal of Urology, Vol.12, No.4, pp. 2726-2726, 2005
Abstract This article has no abstract. More >

View

37

Download

34

Open Access

ARTICLE

J. Curtis Nickel¹, Jay C. Lee², John E. Grantmyre³, Dimitris Polygenis⁴
Canadian Journal of Urology, Vol.12, No.4, pp. 2728-2737, 2005
Abstract Objective: To characterize the natural history of uncomplicated urinary tract infection (uUTI) in a Canadian primary care environment from the patient's perspective.
Materials and methods: Female patients (n = 2323) with symptoms of uUTI were recruited by 581 family physicians who collected baseline demographic and clinical data and prescribed 500 mg/day extended release ciprofloxacin (Cipro® XL™). Follow-up data were collected 4 and 10 days later by patient telephone interview assessing uUTI symptoms, medication compliance, time to symptom resolution, impact on usual activities and overall satisfaction.
Results: Patients (mean age 40) had on average 3.56 uUTI symptoms at baseline,… More >

View

39

Download

27

Open Access

ARTICLE

R. Samant^1,2, I. Alomary^1,2
Canadian Journal of Urology, Vol.12, No.4, pp. 2738-2744, 2005
Abstract Purpose: Historically adjuvant radiotherapy has been routinely recommended for stage I seminoma patients but surveillance has become an increasingly popular option over the last decade. We therefore decided to review the approach currently used by the radiation oncologists at our center.
Methods: A 14-item questionnaire evaluating physician opinions about treatment options for stage I seminoma patients was developed at the Ottawa Hospital Regional Cancer Centre (OHRCC). It was sent to all the radiation oncologists at OHRCC treating genitourinary (GU) malignancies for self-completion.
Results: All the GU radiation oncologists completed the survey for a response rate of 100% (7/7).… More >

View

35

Download

27

Open Access

ARTICLE

Fred Saad¹, J. Curtis Nickel², Luc Valiquette¹, Richard Casey³, Irwin Kuzmarov⁴, Mostafa Elhilali⁵
Canadian Journal of Urology, Vol.12, No.4, pp. 2745-2754, 2005
Abstract Introduction and objectives: A novel slow release formulation of alfuzosin should improve compliance by reducing dosing to one 10 mg tablet per day. The current study examined efficacy, at 9 days and 3 months, and safety of this formulation of alfuzosin in BPH patients.
Methods: ALF-X was a 3-month, non-comparative, observational study of 353 BPH patients from 39 Canadian Urology centres.
Results: At baseline (BL), mean age was 63.1±9.01 years, 92.6% of patients were Caucasian, 3.4% had a history of acute urinary retention, mean duration of the micturition disorder was 48.6±54.15 months, and mean PSA was 3.3±6.65 ng/mL.… More >

View

37

Download

25

Open Access

ARTICLE

Ross E. Gray¹, Richard J. Wassersug², Christina Sinding³, Angela M. Barbara¹, Christine Trosztmer¹, Neil Fleshner⁴
Canadian Journal of Urology, Vol.12, No.4, pp. 2755-2763, 2005
Abstract Objective: This exploratory study was intended to investigate men's ways of integrating and understanding experiences with Androgen Deprivation Therapy (ADT), including how hormone treatment affected their sense of identity.
Patients and methods: Twelve men, averaging 61 years of age and treated with ADT, participated in a single interview about their experiences with prostate cancer and hormone treatment. In keeping with a qualitative approach, questions were initially open-ended, with patients encouraged to describe experiences in their own words.
Results: Seven prominent themes appeared in the interviews: 1) starting on hormones, 2) matching expectations with reality, 3) tracking changes, 4)… More >

View

34

Download

26

Open Access

HOW I DO IT

Nicholaus Bauman, Robert Sabbagh, Rajendar Hanmiah, Anil Kapoor
Canadian Journal of Urology, Vol.12, No.4, pp. 2764-2768, 2005
Abstract Emphysematous pyelonephritis is a serious suppurative infection of the renal and extrarenal tissues. Controversies exist surrounding the appropriate management of this life-threatening condition with advocates for both medical management alone and percutaneous drainage combined with nephrectomy.
The laparoscopic approach for nephrectomy is quickly becoming the standard of care for benign disease of the kidney and low-stage renal cancers. We report a case of a 60-year-old diabetic male undergoing successful laparoscopic nephrectomy for right emphysematous pyelonephritis, and our procedural technique. To our knowledge, this is the first report of laparoscopic nephrectomy in the setting of emphysematous pyelonephritis.
More >

View

31

Download

23

Open Access

RESIDENT’S CORNER

Thai T. Nguyen, Bernard Fallon, Howard N. Winfield
Canadian Journal of Urology, Vol.12, No.4, pp. 2769-2771, 2005
Abstract Guaifenesin is a commonly used expectorant whose use may lead to the occasional formation of guaifenesin urinary stones. We herein describe a patient who was taking 2400 mg Guaifenesin per day as part of his treatment for asthma. He had a past history of a guaifenesin stone removed ureteroscopically. His current presentation was with a 9 mm by 6 mm stone in the upper left ureter, seen on CT scan, and treated initially with a ureteral stent and hydration. After 3 weeks, the stone had disappeared, as confirmed by repeat CT scan. The genesis and More >

View

43

Download

28

Open Access

RESIDENT’S CORNER

Mohammad Al-Omar¹, Kevin Kwan¹, Edward Tweedie², Patrick P. W. Luke¹
Canadian Journal of Urology, Vol.12, No.4, pp. 2772-2773, 2005
Abstract Aggressive angiomyxoma is a rare locally invasive non-metastasizing soft tissue neoplasm that is most commonly located in the female pelvis and perineum. We report a case of aggressive angiomyxoma arising from the epididymis of a young male, which was treated by radical orchiectomy. More >

View

40

Download

27

Open Access

RESIDENT’S CORNER

A. K. Pelletier, P. A. M. Anderson, R. D. Schwarz
Canadian Journal of Urology, Vol.12, No.4, pp. 2774-2777, 2005
Abstract Introduction: Endoscopic techniques are becoming increasingly accepted for treatment of vesicoureteric reflux as alternatives to open surgical reimplantation. However, there is some debate about the ideal injectable material. Since we have accumulated experience with several substances, an opportunity existed to compare them.
Materials and methods: From 1991 to 2003, 101 children with vesicoureteric reflux were treated by endoscopic subureteric injection either once (74) or twice (27) by either of two pediatric urologists. There were a total of 165 ureteral injections, 83 with polytetrafluoroethylene (Teflon®), 73 with polydimethylsiloxane (Macroplastique®), and 9 with collagen. Each child was evaluated pre-operatively… More >

View

36

Download

23